These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 808047)
21. [Effect of purified proteases (I-elastase, II-protease) on the course of Pseudomonas aeruginosa infection in DBA/2H mice]. Pajdak E; Stankiewicz D Med Dosw Mikrobiol; 1982; 34(3-4):139-43. PubMed ID: 6820452 [No Abstract] [Full Text] [Related]
22. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota. Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795 [TBL] [Abstract][Full Text] [Related]
23. Passive protection of NMRI mice against Serratia marcescens: comparative efficacy of commercial human IgG immunoglobulin preparations and rabbit anti-O, -H, -K, -life cell and -protease immune sera. Traub WH Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):480-8. PubMed ID: 6202079 [TBL] [Abstract][Full Text] [Related]
24. Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281 [TBL] [Abstract][Full Text] [Related]
25. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Marquart ME; Caballero AR; Chomnawang M; Thibodeaux BA; Twining SS; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3761-8. PubMed ID: 16186360 [TBL] [Abstract][Full Text] [Related]
26. Corneal ulcers caused by protease and elastase from Pseudomonas aeruginosa. Kawaharajo K; Abe C; Homma JY; Kawano M; Goto E Jpn J Exp Med; 1974 Oct; 44(5):435-42. PubMed ID: 4215914 [No Abstract] [Full Text] [Related]
27. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines. Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018 [TBL] [Abstract][Full Text] [Related]
28. Anti-Pseudomonas immunoglobulin I. Immunization of sheep. Schiller B; Buchowicz I; Korbecki M; Lysakowska E; Rudnicka W; Robaczewska E Arch Immunol Ther Exp (Warsz); 1981; 29(5):627-33. PubMed ID: 6812540 [TBL] [Abstract][Full Text] [Related]
30. Effect of phosphoramidon on protection against corneal ulcer caused by elastase and protease from Pseudomonas aeruginosa. Kawaharajo K; Homma JY; Aoyagi T; Umezawa H Jpn J Exp Med; 1982 Oct; 52(5):271-2. PubMed ID: 6820397 [No Abstract] [Full Text] [Related]
31. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960 [TBL] [Abstract][Full Text] [Related]
32. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice]. Trautmann M; Brückner O; Hahn H Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803 [TBL] [Abstract][Full Text] [Related]
33. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231 [TBL] [Abstract][Full Text] [Related]
34. Purification and properties of a protease with elastase activity from Pseudomonas aeruginosa. Wretlind B; Wadström T J Gen Microbiol; 1977 Dec; 103(2):319-27. PubMed ID: 413876 [TBL] [Abstract][Full Text] [Related]
35. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa. Weimer ET; Ervin SE; Wozniak DJ; Mizel SB Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586 [TBL] [Abstract][Full Text] [Related]
36. [In vivo effects of Pseudomonas aeruginosa proteases on human plasma proteins]. Müller HE Dtsch Med Wochenschr; 1971 Jul; 96(31):1278-82. PubMed ID: 4997689 [No Abstract] [Full Text] [Related]
37. [Use of the indirect hemagglutination reaction for detecting antibodies ot dermatophyte proteolytic enzymes]. Kashkin AP; Makhovenko LV Vestn Dermatol Venerol; 1978 Jun; (6):26-30. PubMed ID: 676480 [No Abstract] [Full Text] [Related]
38. [Production of antihaptene antisera. Comparison of methods of immunisation (author's transl)]. Cesselin F; Lagoguey M; Chauffournier JM; Guignard M; Desgrez P Pathol Biol (Paris); 1976 Jan; 24(1):41-6. PubMed ID: 131285 [TBL] [Abstract][Full Text] [Related]
39. Increases vascular permeability caused by the trypsin-like enzymes purified from rat submandibular gland. Ekfors TO; Hopsu-Havu VK; Malniharju T Acta Physiol Scand; 1969; 75(1):157-60. PubMed ID: 5785137 [No Abstract] [Full Text] [Related]